Catalyst Pharmaceuticals Inc. (CPRX)

Catalyst Pharmaceuticals Inc. (CPRX $24.94)
- $24.94 P/E (TTM): 14.76X Cap: $3.04B
- View CPRX Profile
- View Questions on CPRX

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Intuitive Surgical Inc. (ISRG $450.62)
- $450.62 P/E (TTM): 57.26X Cap: $160.02B
- View ISRG Profile
- View Questions on ISRG
Vertex Pharmaceuticals Incorporated (VRTX $436.27)
- $436.27 P/E (TTM): 28.53X Cap: $111.01B
- View VRTX Profile
- View Questions on VRTX
AbbVie Inc. (ABBV $207.94)
- $207.94 P/E (TTM): 88.11X Cap: $367.79B
- View ABBV Profile
- View Questions on ABBV
Johnson & Johnson (JNJ $238.46)
- $238.46 P/E (TTM): 21.62X Cap: $574.35B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $939.47)
- $939.47 P/E (TTM): 40.94X Cap: $887.62B
- View LLY Profile
- View Questions on LLY
Merck & Company Inc. (MRK $121.42)
- $121.42 P/E (TTM): 16.68X Cap: $300.06B
- View MRK Profile
- View Questions on MRK
iShares Biotechnology ETF (IBB $169.37)
- $169.37 P/E (TTM): 20.63X Cap: $8.17B
- View IBB Profile
- View Questions on IBB
IDEXX Laboratories Inc. (IDXX $563.00)
- $563.00 P/E (TTM): 43.04X Cap: $44.76B
- View IDXX Profile
- View Questions on IDXX
Halozyme Therapeutics Inc. (HALO $67.82)
- $67.82 P/E (TTM): 26.81X Cap: $8.03B
- View HALO Profile
- View Questions on HALO
Incyte Corporation (INCY $96.07)
- $96.07 P/E (TTM): 14.99X Cap: $19.11B
- View INCY Profile
- View Questions on INCY
Catalyst Pharmaceuticals Inc. (CPRX $24.94)
- $24.94 P/E (TTM): 14.76X Cap: $3.04B
- View CPRX Profile
- View Questions on CPRX
Gilead Sciences CDR (CAD Hedged) (GILD $28.28)
- $28.28 P/E (TTM): 365.76X Cap: $235.79B
- View GILD Profile
- View Questions on GILD

Q: We have accumulated 11 healthcare stocks and 1 ETF, While LLY and ISRG are at half positions the rest are at initial 25% positions. Please advise [help!] us get to a more concentrated portfolio with a 3+ year horizon for reasonable opportunities in healthcare

Read Answer Asked by sam on January 13, 2026

AbbVie Inc. (ABBV $207.94)
- $207.94 P/E (TTM): 88.11X Cap: $367.79B
- View ABBV Profile
- View Questions on ABBV
Eli Lilly and Company (LLY $939.47)
- $939.47 P/E (TTM): 40.94X Cap: $887.62B
- View LLY Profile
- View Questions on LLY
Cipher Pharmaceuticals Inc. (CPH $18.65)
- $18.65 P/E (TTM): 13.06X Cap: $471M
- View CPH Profile
- View Questions on CPH
- View Reports on CPH
Halozyme Therapeutics Inc. (HALO $67.82)
- $67.82 P/E (TTM): 26.81X Cap: $8.03B
- View HALO Profile
- View Questions on HALO
uniQure N.V. (QURE $15.38)
- $15.38 Cap: $1.08B
- View QURE Profile
- View Questions on QURE
Catalyst Pharmaceuticals Inc. (CPRX $24.94)
- $24.94 P/E (TTM): 14.76X Cap: $3.04B
- View CPRX Profile
- View Questions on CPRX

Q: Hi, could you suggest a couple each of your fav. small, mid and large cap biotech stocks and why you like them.

thanks, M

Read Answer Asked by Mark on October 08, 2025

Catalyst Pharmaceuticals Inc. (CPRX $24.94)
- $24.94 P/E (TTM): 14.76X Cap: $3.04B
- View CPRX Profile
- View Questions on CPRX
Elevance Health Inc. (ELV $311.53)
- $311.53 P/E (TTM): 12.41X Cap: $68.43B
- View ELV Profile
- View Questions on ELV

Q: What's your opinion about these two stocks? Buy/Hold/Sell? Timeframe: 3-5 years. Risk tolerance: moderate.

Read Answer Asked by Paul on September 12, 2025